13 March 2024Use of multiplexed optical detection techniques to elucidate anti-tumor immune responses in human basal cell carcinomas (BCC) treated with photodynamic therapy
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) holds great promise as a treatment option for human basal cell carcinoma (BCC), the most common of all cancers. Recent evidence suggests that PDT is an immune-altering modality. Here we describe a clinical trial (NCT05020912) to examine the effects of ALA-PDT upon the tumor immune landscape within BCC tumors pre- and post-treatment, to better understand the nature of the tumor-infiltrating immune cells, and accompanying changes in systemic anti-tumor immunity. If better understood, such knowledge could be harnessed to improve therapeutic responses to PDT.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Edward V. Maytin, Alan Shen, Lauren Heusinkveld, Jackson Hanna, Sanjay Anand, Judy Drazba, Claudia Marcela Diaz-Montero, Haidong Dong, "Use of multiplexed optical detection techniques to elucidate anti-tumor immune responses in human basal cell carcinomas (BCC) treated with photodynamic therapy," Proc. SPIE PC12823, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXXII, PC1282305 (13 March 2024); https://doi.org/10.1117/12.3021791